市场快照
| Study Period: | 2018 - 2026 |
| Base Year: | 2021 |
| CAGR: | 3.2 % |
|
Need a report that reflects how COVID-19 has impacted this market and its growth?
市场概况
预计欧洲人造器官和仿生植入物市场在预测期内将以 3.2% 的复合年增长率增长。该国市场的增长可归因于残疾、器官衰竭和供体器官稀缺的发病率增加。
此外，肾脏疾病、急性肾功能衰竭的患病率上升以及人口老龄化导致器官衰竭的增加是推动该地区市场的更多因素。生物医学领域的迅速参与使器官移植成为一种普遍的做法。根据英国心脏基金会的估计，2018 年，英国约有 700 万人患有心脏和循环系统疾病，每年与心脏和循环系统疾病相关的医疗保健费用估计为 90 亿英镑。因此，慢性病的日益流行有助于推动对人造器官和仿生学的需求。此外，仿生骨科、仿生眼和外骨骼的发展正在推动市场增长。
Scope of the report
As per the scope of the report, artificial organs and bionics are man-made devices that can be implanted or integrated with humans, to either replace a natural organ or provide support for the purpose of restoring specific function or a group of related functions, helping the patient to return to his normal life.
| By Product | |||||||
| |||||||
|
| Geography | ||||||||
|
主要市场趋势
预计心脏仿生细分市场在预测期内将有较高的增长率
心脏仿生学包括心脏瓣膜、心室辅助装置、起搏器等。该细分市场的高增长率归因于心血管疾病患病率的增加，以及该国老年人口的增加。根据欧洲心脏网络，每年心血管疾病 (CVD) 在欧洲导致 390 万人死亡，在欧盟导致超过 180 万人死亡。中欧和东欧的缺血性心脏病 (IHD) 和中风死亡率通常高于北欧、南欧和西欧。在欧洲，心血管疾病导致的死亡人数和疾病负担是艾滋病、肺结核和疟疾加起来的 11 倍。因此，随着庞大的患者群体，预计在预测期内对心脏仿生学和人造心脏的需求将会上升。
To understand key trends, Download Sample Report
竞争格局
欧洲人工器官和仿生植入物市场与几家主要参与者竞争适度。实施的一些战略包括协议、协作模式、业务扩展和产品开发。大多数市场参与者都专注于将技术先进的产品引入市场，以获得最大的市场份额。
Table of Contents
-
1. INTRODUCTION
-
1.1 Study Deliverables
-
1.2 Study Assumptions
-
1.3 Scope of the Study
-
-
2. RESEARCH METHODOLOGY
-
3. EXECUTIVE SUMMARY
-
4. MARKET DYNAMICS
-
4.1 Market Overview
-
4.2 Market Drivers
-
4.2.1 Increased Incidence of Disabilities, Organ Failures and Scarcity of Donor Organs
-
4.2.2 Technological Advancements Leading to Enhanced Applications
-
-
4.3 Market Restraints
-
4.3.1 Expensive Procedures and Fear of Device Malfunction and its Consequences
-
-
4.4 Porter's Five Force Analysis
-
4.4.1 Threat of New Entrants
-
4.4.2 Bargaining Power of Buyers/Consumers
-
4.4.3 Bargaining Power of Suppliers
-
4.4.4 Threat of Substitute Products
-
4.4.5 Intensity of Competitive Rivalry
-
-
-
5. MARKET SEGMENTATION
-
5.1 By Product
-
5.1.1 Artificial Organs
-
5.1.1.1 Artificial Heart
-
5.1.1.2 Artificial Kidney
-
5.1.1.3 Cochlear Implants
-
5.1.1.4 Others
-
-
5.1.2 Bionics
-
5.1.2.1 Vision Bionics
-
5.1.2.2 Ear Bionics
-
5.1.2.3 Orthopedic Bionic
-
5.1.2.4 Cardiac Bionics
-
5.1.2.5 Others
-
-
-
5.2 Geography
-
5.2.1 Europe
-
5.2.1.1 Germany
-
5.2.1.2 United Kingdom
-
5.2.1.3 France
-
5.2.1.4 Italy
-
5.2.1.5 Spain
-
5.2.1.6 Rest of Europe
-
-
-
-
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
-
6.1.1 Boston Scientific Corporation
-
6.1.2 Otto Bock Holding GmbH & Co. KG
-
6.1.3 Medtronic plc
-
6.1.4 Zimmer Biomet
-
6.1.5 Sonova Holding AG (Advanced Bionics)
-
6.1.6 Edwards Lifesciences Corporation
-
6.1.7 Terumo Medical Corporation
-
6.1.8 OSSUR
-
*List Not Exhaustive -
-
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
You can also purchase parts of this report. Do you want to check out a section wise price list?
Frequently Asked Questions
What is the study period of this market?
The Europe Artificial Organs and Bionic Implants Market market is studied from 2018 - 2026.
What is the growth rate of Europe Artificial Organs and Bionic Implants Market?
The Europe Artificial Organs and Bionic Implants Market is growing at a CAGR of 3.2% over the next 5 years.
Who are the key players in Europe Artificial Organs and Bionic Implants Market?
Boston Scientific Corporation, Medtronic plc, Zimmer Biomet, Sonova Holding AG(Advanced Bionics), Otto Bock Holding GmbH & Co. KG are the major companies operating in Europe Artificial Organs and Bionic Implants Market.
